MOAP1 and colorectal carcinoma: To determine the clinical role of miR-92a-3p, its expression was analyzed in normal and cancer tissues from CRC patients, showing that the expression was increased in patients with CRC metastasis and fluorouracil/oxaliplatin (5-FU/L-OHP) therapy resistance and inversely correlated with FBXW7 and MOAP1 [140].